267 related articles for article (PubMed ID: 2084321)
1. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
Antes U; Heinz HP; Hartung K; Loos M
Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
Uwatoko S; Mannik M
J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
[TBL] [Abstract][Full Text] [Related]
4. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
[TBL] [Abstract][Full Text] [Related]
5. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).
van den Berg RH; Siegert CE; Faber-Krol MC; Huizinga TW; van Es LA; Daha MR
Clin Exp Immunol; 1998 Feb; 111(2):359-64. PubMed ID: 9486404
[TBL] [Abstract][Full Text] [Related]
6. Autoreactivity to mouse C1q in a murine model of SLE.
Trinder PK; Maeurer MJ; Schorlemmer HU; Loos M
Rheumatol Int; 1995; 15(3):117-20. PubMed ID: 8588121
[TBL] [Abstract][Full Text] [Related]
7. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
[TBL] [Abstract][Full Text] [Related]
8. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against C1q in patients with systemic lupus erythematosus.
Trendelenburg M
Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
[TBL] [Abstract][Full Text] [Related]
10. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
11. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
Wisnieski JJ; Jones SM
J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
[TBL] [Abstract][Full Text] [Related]
12. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
13. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
Holers VM
J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
[TBL] [Abstract][Full Text] [Related]
14. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
16. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
Agnello V; Mitamura T
Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
Cook AD; Rowley MJ; Wines BD; Mackay IR
J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]